Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 May;32(5):e206-16.
doi: 10.1097/INF.0b013e3182863a1c.

Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis

Mohan Pammi et al. Pediatr Infect Dis J. 2013 May.

Abstract

Background: Candida is the third most common cause of late-onset neonatal sepsis in infants born at <1500 g. Candida parapsilosis infections are increasingly reported in preterm neonates in association with indwelling catheters.

Methods: We systematically reviewed neonatal literature and synthesized data pertaining to percentage of C. parapsilosis infections and mortality by meta-analyses. We also reviewed risk factors, virulence determinants, antimicrobial susceptibility patterns and outlined clinical management strategies.

Results: C. parapsilosis infections comprised 33.47% (95% confidence interval [CI]: 30.02, 37.31) of all neonatal Candida infections. C. parapsilosis rates were similar in studies performed before the year 2000, 33.53% (95% CI: 30.06, 37.40) (28 studies), to those after 2000, 27.00% (95% CI: 8.25, 88.37) (8 studies). The mortality due to neonatal C. parapsilosis infections was 10.02% (95% CI: 7.66, 13.12). Geographical variations in C. parapsilosis infections included a low incidence in Europe and higher incidence in North America and Australia. Biofilm formation was a significant virulence determinant and predominant risk factors for C. parapsilosis infections were prematurity, prior colonization and catheterization. Amphotericin B remains the antifungal drug of choice and combination therapy with caspofungin or other echinocandins may be considered in resistant cases.

Conclusion: C. parapsilosis is a significant neonatal pathogen, comprises a third of all Candida infections and is associated with 10% mortality. Availability of tools for genetic manipulation of this organism will identify virulence determinants and organism characteristics that may explain predilection for preterm neonates. Strategies to prevent horizontal transmission in the neonatal unit are paramount in decreasing infection rates.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Forest plot depicting percentage of C. parapsilosis infections
Red squares and black horizontal lines through the squares represent proportion with 95% confidence intervals. First subgroup labeled 1.1.1 represents studies that were predominantly performed before the year 2000 and the second subgroup labeled 1.1.2 represents studies performed after the year 2000. Abbreviations: CP – Candida parapsilosis, SE- standard error, IV- inverse variance, Random-Random effects model for meta-analyses, CI- confidence intervals.
Fig. 2
Fig. 2. Forest plot of percentage of C. parapsilosis infections by geographical regions
Red squares and black horizontal lines through the squares represent proportion with 95% confidence intervals. Studies were sub grouped into 5 different regions; North America (12 studies), South America (2 studies), Europe (12 studies), Asia (7 studies) and Australia (2 studies). Abbreviations: CP – Candida parapsilosis, SE- standard error, IV- inverse variance, Random-Random effects model for meta-analyses, CI- confidence intervals.
Fig. 3
Fig. 3. Mortality of C. parapsilosis infections
Red squares and black horizontal lines through the squares represent proportion with 95% confidence intervals. The combined mortality of neonatal C. parapsilosis infection was 10.02 [95% CI 7.66, 13.12]. Abbreviations: CP – Candida parapsilosis, SE- standard error, IV- inverse variance, Random- Random effects model for meta-analyses, CI- confidence intervals.
Fig. 4
Fig. 4. Electron microscopy of in vivo biofilms
Biofilm formation on central venous catheters inserted into rats and inoculated with C. parapsilosis (wild type strain CLIB214) and a bcr1 deletion (CDb71) strain. The catheters were removed after 24 hrs and visualized using scanning electron microscopy at two different magnifications. The wild type strain formed a thick biofilm, whereas the bcr1 deletion strain displayed impaired biofilm formation, indicating the essential role of the transcription factor BCR1 in biofilm formation. [Reproduced with permission from Ding C, Vidanes GM, Maguire SL, Guida A, Synnott JM, Andes DR and Geraldine Butler. Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans. PLoS One. 2011;6(12):e28151].

Similar articles

Cited by

References

    1. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291. - PubMed
    1. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. - PubMed
    1. Almirante B, Rodriguez D, Cuenca-Estrella M, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44:1681–1685. - PMC - PubMed
    1. Brito LR, Guimaraes T, Nucci M, et al. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol. 2006;44:261–266. - PubMed
    1. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50:243–260. - PubMed

Publication types

Substances